	Does an emphasis on urinary continence compromise oncological outcomes after robot-assisted radical prostatectomy? World J Urol Matsumoto K, Fukumoto K, Yasumizu Y, Tanaka N, Takeda T, Asanuma H. PMID: 42496719 [PubMed - indexed for MEDLINE]
	Histotripsy for renal cell carcinoma: from animal studies to clinical application. Int J Hyperthermia Mutlu A, Falk KL, Kisting AL, Knavel Koepsel EM, Wagner MG, Hinshaw JL, Shapiro DD, Abel EJ, Swietlik JF, Laeseke PF, Ziemlewicz TJ, Lee FT, Golden ED. PMID: 42495873 [PubMed - indexed for MEDLINE]
	ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics. Am J Nucl Med Mol Imaging Liang SH. PMID: 42495193 [PubMed]
	From Diagnosis to Disclosure: Navigating Genetic Counseling Dilemmas in BRCA2-Associated Prostate Cancer in the Middle East. Case Rep Genet van Wyk C, Abdulrahim R, Crous I, Al Saegh A, Al Balushi A, Al Muhairi B, Al Kiyumi S, Al Malki S, Al Harthy M. PMID: 42494986 [PubMed]
	Development and validation of a machine learning-based early warning model for bone metastasis in newly diagnosed prostate cancer. Front Oncol Wang L, He W, Zhao C, Lv Q, Qiu T, Zhai J, Mao K, Li D, Wen X. PMID: 42494601 [PubMed]
	Sequential gemcitabine-docetaxel in BCG-naÃ¯ve and BCG-failure non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Front Oncol Alhubaishy B, Beshawri I, Abulreish I, Alnajar O, Radhi H, Saleh A, Alwafi S, Halawani A. PMID: 42494591 [PubMed]
	Preliminary study on intravesical instillation of IL-12 mRNA lipid nanoparticles for the treatment of bladder cancer. Tumori Ouyang B, Wu Z, Li J, Zhu G, Shen Y, Lang M. PMID: 42494051 [PubMed - as supplied by publisher]
	Comment on: Cardiovascular and prostate cancer risk associated to testosterone replacement therapy - a systematic review and meta-analysis of 41 randomized controlled trials. Int J Impot Res Sharifan A. PMID: 42493582 [PubMed - as supplied by publisher]
	Electronic nose-based urinary volatilome profiling accurately discriminates bladder cancer from healthy controls: A prospective diagnostic study. Urol Oncol Filianoti A, Costantini M, Rosca V, Mastroianni R, Tuderti G, Ghezzo N, Simone G. PMID: 42493403 [PubMed - as supplied by publisher]
	Circulating KIM-1 and survival outcomes in renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol Lu J, Luo B, Xue C, Shen J. PMID: 42493401 [PubMed - as supplied by publisher]
	Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol 2026;89:437-45. Eur Urol Di Bello F, Gallioli A, Breda A, Palou J. PMID: 42493340 [PubMed - as supplied by publisher]
	Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Effect of [(68)Ga]Ga-PSMA-11 PET-CT in the Diagnosis of Prostate Cancer in Men with Equivocal or Clinically High-risk Non-suspicious Findings on Multiparametric MRI (PRIMARY2): A Multicenter, Non-inferiority, Phase 3, Randomized Controlled Trial. Lancet Oncol 2026;27:839-848. Eur Urol Uleri A, Baboudjian M, Lughezzani G, Ploussard G. PMID: 42493339 [PubMed - as supplied by publisher]
	Re: Robert M. Meier, Nima Aghdam, Alan C. Beckman et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029. Eur Urol Kim JS, Chang AR, Kim JH. PMID: 42493338 [PubMed - as supplied by publisher]
	Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial. J Immunother Cancer Eefsen RL, Spindler NJ, Theile S, Al-Farra G, Hendel HW, Lorentzen T, Fredberg Persson G, Behrens CP, Chen IM, Madsen K, Sengeløv L, Svane IM, Lindberg H, Kongsted P, Nielsen DL. PMID: 42493213 [PubMed - indexed for MEDLINE]
	Outcome Prediction After [(177)Lu]Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: External Validation of a [(68)Ga]Ga-PSMA-11 PET-Based Model with [(18)F]F-Flotufolastat. J Nucl Med Karimzadeh A, Fütterer C, Hansen K, Coban Ö, Hein S, Nekolla S, Heck M, Tauber R, Haller B, Gafita A, Weber WA, Eiber M, Rauscher I. PMID: 42492997 [PubMed - as supplied by publisher]
	Early treatment with rasburicase and risk of kidney replacement therapy and death in adults with tumour lysis syndrome: emulated target trial. BMJ Shenoy T, Sanchez-Almanzar D, Dias JA, Hayden R, Shashaty MG, Aklilu AM, Patell R, Anand S, Renaghan A, Bassil C, Neyra JA, Bansal A, Shah CV, Gupta S, Sise ME, Seethapathy R, Chase S, Thompson C, Radhakrishnan R, Verma E, Ni J, Hoge ST, Lypka V, Ali R, Monson AE, Kaunfer S, Angus E, Griffiths S, Walling C, Al Haddad N, Brotman CH, Miano T, Shirali AC, Turco DJ, Alleyne SA, Shelton K, Shaefi S, Garcia D, Nasim A, Jan N, Nguyen PH, Ziolkowski S, Subramanian N, Subramanian V, Debnath N, Faldu CT, Wickramasinghe K, Donahue BP, Shah A, Shostak J, Jayakumar V, Nadayil J, Baz R, Takeuchi T, Renzi S, Rehman AU, Nombera-Aznaran N, Charkviani M, Kotzin M, Kaiser J, Edwards M, Mathavan A, Mathavan A, Obimdike F, Shah N, LaCasce AS, Armand P, Leaf DE. PMID: 42492944 [PubMed - indexed for MEDLINE]
	The dual role of retinoic acid signaling in clear cell renal cell carcinoma and wilms tumor: A tale of two entities. Biochim Biophys Acta Rev Cancer Qiang SHI, Zehua LI, Huilin FU, Haifeng SHI, Jie GU. PMID: 42492627 [PubMed - as supplied by publisher]
	Revisiting familial aggregation of prostate cancer within the 3D framework of genetics-epigenetics-environment. Mutat Res Rev Mutat Res Shi K, Liang B, He T, Jiang D. PMID: 42492399 [PubMed - as supplied by publisher]
	En bloc versus conventional resection of primary bladder tumor: a systematic review and meta-analysis. Clinics (Sao Paulo) Rezende PD, Hashimoto AS, Lepine H, Micheleto JPC, Cordeiro MD, Mota JM, Nahas WC, Elkoushy M, Shahrour W, Shabana W, Wettstein MS, Ribeiro-Filho LA, Suartz CV. PMID: 42492319 [PubMed - as supplied by publisher]
	Adoption of MRI-guided Prostate Cancer Diagnostics and Surgical Outcomes: A Prospective Multicenter Registry Study. Eur Urol Open Sci Tasios A, Arnold N, Röthlisberger R, Wyler S, Nguyen DP, Abt D, Mattei A, Strebel R, Thalmann G, Schneidewind L, Roth B, Giudici N, Swiss Urology Registry Collaborative Group. PMID: 42491321 [PubMed]

Articles 1 - 20 / 180273

Page 1 of 9014



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy